Trending: Merck Reports Court Win in Diabetes Patent Lawsuit Against Viatris
September 22 2022 - 3:42PM
Dow Jones News
1511 ET -- Merck & Co. is one of the most talked about
companies in the U.S. across all news items in the last 12 hours,
according to Factiva data. Earlier Thursday, Merck said a West
Virginia district court ruled in its favor in a two-patent
infringement suit against Viatris Inc. regarding an ingredient in
medication to treat type 2 diabetes. Also on Thursday, Merck said
it agreed to buy Vence in a deal that would bolster the drugmaker's
animal-health portfolio. Dow Jones & Co. owns Factiva.
(susan.solan@wsj.com)
(END) Dow Jones Newswires
September 22, 2022 15:27 ET (19:27 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Sep 2023 to Sep 2024